JP7531136B2 - Infection Protection Capsule - Google Patents

Description

The present invention relates to an infection protection capsule that can isolate patients with infectious diseases and perform image diagnosis.

Conventionally, imaging diagnostic methods using CT (Computed Tomography) and MRI (Magnetic Resonance Imaging) have been used for patients suffering from underlying diseases or pneumonia.

When using these devices to diagnose patients who are positive or suspected of being positive for an infectious disease, the current situation is that the number of tests is about half of the usual number, as thorough measures must be taken to prevent infection among medical staff and general patients in the hospital, such as securing passageways, frequently changing protective clothing, gloves, masks, face covers, etc. for medical staff, disinfecting contact areas, and ventilating the examination room.

On the other hand, as a device for isolating and transporting patients who are positive for or suspected of being positive for an infectious disease by implementing droplet contact infection prevention measures, a patient transport device equipped with an exhaust unit that purifies and exhausts the air inside the capsule has been disclosed, as in Patent Document 1.

JP 2005-28058 A

However, the configuration of Patent Document 1 is not designed to be used for measurements using diagnostic imaging methods such as CT or MRI, and is not made to a size that can fit into the gantry opening of a CT or MRI. In addition, because it is made of metal such as stainless steel, it is affected by X-rays and electromagnetic waves, and there is a risk of abnormalities occurring if diagnostic imaging is performed on a patient suffering from an infectious disease while they are isolated. Furthermore, in the configuration of Patent Document 1, the capsule is sterilized and disposed of after use, but in light of the recent shortage of medical protective equipment and medical supplies, it is desirable to sterilize the inside of the capsule and reuse it.

In view of these issues, the present invention aims to provide an infection protection capsule that facilitates measurement of infectious disease patients or patients suspected of having an infectious disease using imaging diagnostic methods such as CT or MRI, and reuse after measurement.

One aspect of the present invention is an infection protection capsule for housing a patient with or suspected of having an infectious disease and for use in medical imaging, comprising a body cover section for covering the patient, a bottom section on which the patient lies, an overhead cover section located above the patient's head, a sole cover section located at the patient's feet, and an exhaust mechanism that is in fluid communication with either the overhead cover section or the sole cover section via an opening and a filter, the exhaust mechanism creating negative pressure inside the infection protection capsule, and the body cover section engaging with the bottom section in an openable and closable manner.

The present invention makes it possible to perform measurements using diagnostic imaging methods such as CT and MRI while avoiding the spread of infectious diseases to medical personnel and general patients, and furthermore makes it possible to easily disinfect the inside of the infection protection capsule so that it can be reused after measurements have been taken.

1 is an overall schematic diagram showing an infection protection capsule according to one embodiment of the present invention; 1 is a schematic diagram showing an example of use of an infection protection capsule according to one embodiment of the present invention. FIG. 1( c ) is a partially enlarged view of an infection protection capsule according to one embodiment of the present invention. 13A and 13B are graphs and diagrams relating to negative pressure within an infection protection capsule in accordance with an embodiment of the present invention; 1 is a graph showing disinfection results by UV irradiation in an infection protection capsule according to one embodiment of the present invention. 1 is a graph showing disinfection results of an infection protection capsule according to one embodiment of the present invention. 1 is a schematic cross-sectional view of an infection protection capsule according to one embodiment of the present invention when a virus is sprayed into the capsule, and a graph showing the results of measuring lysis plaques. 1 is a graph showing the results of measuring the number of plaques over time when a virus is sprayed onto a material used in an infection protection capsule according to one embodiment of the present invention. 13 is a modified infection protection capsule according to one embodiment of the present invention.

MODE FOR CARRYING OUT THEINVENTION

The following describes in detail an embodiment of the present invention with reference to the drawings.

[Outline of infection protection capsule]
(Capsule structure)
Fig. 1(a) is a schematic side view of an infection protection capsule according to one embodiment of the present invention, Fig. 1(b) is a schematic top view of an infection protection capsule according to one embodiment of the present invention, Fig. 1(c) is a schematic view of the infection protection capsule of Fig. 1(a) as viewed from the right side on a sheet of paper, and Fig. 1(d) is a schematic view of the infection protection capsule of Fig. 1(a) as viewed from the left side.

The infection protection capsule 1 of the present invention is configured so that a patient can lie inside the infection protection capsule 1, and is equipped with a body cover section 2 that covers the patient, a bottom section 3 on which the patient lies, an overhead cover section 4 that is located above the patient's head, a sole cover section 5 that is located at the patient's feet, and an exhaust mechanism 6 (not shown) near the overhead cover section 4.

The body cover part 2 covers one side of the patient from the other side, and forms part of the space that accommodates the patient. The body cover part 2 is formed so as to be detachable from the bottom part 3. For example, both ends of the body cover part 2 parallel to the longitudinal direction may be engaged with the ends 3A and 3C of the bottom part 3. Also, the longitudinal end of the body cover part 2 may be engaged with the end 3A of the bottom part 3, and the other longitudinal end of the body cover part 2 may be engaged with the end 3C of the bottom part 3. The detachable structure of the body cover part 2 and the bottom part 3 will be described later.

The shape of the body cover part 2 may be a single sheet, or it may be made up of multiple sheets joined together at their ends. Also, sheets with a corrugated structure may be joined together so that the interior does not deform even when negative pressure is applied.

The material of the body cover part 2 is a material that does not affect the X-rays and electromagnetic waves used when taking pictures using a medical image processing device 10 such as a CT scan or MRI, and it is sufficient that it is transparent. In addition, the material of the body cover part 2 has a rigidity that makes it difficult to deform when negative pressure is applied inside the capsule. Furthermore, it is preferable that the material is durable against disinfectants such as hypochlorous acid water, sodium hypochlorite, and alcohol, as well as ultraviolet (UV: Ultra Violet) radiation.

The material used for the body cover part 2 can be, for example, a thermoplastic resin such as polycarbonate, PET (PolyEthylene Terephthalate), or Mylar (registered trademark). Polycarbonate is preferable. The thickness of the body cover part 2 may be 0.5 mm or more. This makes the body cover part 2 less likely to deform when negative pressure is created inside the infection protection capsule 1, and provides rigidity against negative pressure.

The body cover portion 2 of the infection protection capsule of the present invention is preferably formed of polycarbonate, as described above. Polycarbonate is a rigid material, and is hardly deformed even when negative pressure is applied inside the infection protection capsule. In addition, if the material is transparent like polycarbonate, the patient accommodated in the capsule is less likely to feel a sense of pressure, and medical personnel outside the infection protection capsule 1 can check the internal situation. Furthermore, it is easy to wipe the inside of the infection protection capsule 1 after use when disinfecting it with alcohol or the like. Disinfection of the inside of the infection protection capsule 1 is not limited to wiping with alcohol.

The body cover section 2 may be provided with ports for an oxygen mask, an IV drip, and ports for inserting gloves or the like to support the patient. These ports can be opened and closed.

The bottom surface part 3 is located on the back of the patient and forms part of the space that accommodates the patient. The bottom surface part 3 is configured so that the patient can lie down, and an overhead cover part 4 is joined to an end part 3B of the bottom surface part 3, and a sole cover part 5 is joined to an end part 3D of the bottom surface part 3. The cross-sectional shape of the bottom surface part 3 may be a square shape or a concave shape that forms a concave part on the patient side.

The material of the bottom part 3 is not affected by X-rays or electromagnetic waves used in CT scans or MRI scans, and may be durable enough for a patient to lie down on. For example, the material of the bottom part 3 may be a CFRP (carbon fiber reinforced plastic) plate, wood, Bakelite plate, MC nylon plate, Teflon (registered trademark) plate, polystyrene plate, graphite plate, polypropylene plate, ABS resin plate, or polypentane acetal (POM) plate. Wood is preferable, and polycarbonate may be attached to the patient side. This makes it easier to disinfect the inside of the infection protection capsule.

The overhead cover part 4 is located above the patient's head and forms part of the space for accommodating the patient. As shown in FIG. 1(c), the overhead cover part 4 is located between the body cover part 2 and the bottom part 3, forming a semicircular shape. The overhead cover part 4 has an opening. The opening of the overhead cover part 4 is in fluid communication with the outside or other exhaust treatment devices via an exhaust filter 4a. The exhaust filter 4a may be installed in the overhead cover part 4, or may be installed in the piping leading from the opening. The shape of the overhead cover part 4 is semicircular, but is not limited to this and may be a polygonal shape such as a square.

The material of the overhead cover part 4 may be any material that does not affect the X-rays or electromagnetic waves used in CT scans or MRI scans. For example, the material of the overhead cover part 4 may be a CFRP (carbon fiber reinforced plastic) plate, wood, Bakelite plate, MC nylon plate, Teflon plate, polystyrene plate, graphite plate, polypropylene plate, ABS resin plate, or polypentane acetal (POM) plate. Wood is preferable, and polycarbonate may be attached to the patient side. This makes it easier to disinfect the inside of the infection protection capsule.

The exhaust filter 4a filters and removes infectious microorganisms such as viruses from the air exhausted from the infection protection capsule 1. The exhaust filter 4a is a HEPA filter with a particle collection efficiency of 99.97% or more for particles with a particle diameter of 0.3 microns. The exhaust filter 4a is not limited to a HEPA filter, and a ULPA filter or the like may also be used. This makes it possible to filter and remove infectious microorganisms inside the infection protection capsule 1.

The sole cover part 5 is located on the sole of the patient's foot and forms part of the space for accommodating the patient. As shown in FIG. 1(d), the sole cover part 5 faces the overhead cover part 4, is located between the body cover part 2 and the bottom part 3, and forms a semicircular shape. The sole cover part 5 has an opening, which is covered by an air supply filter 5a. The opening of the sole cover part 5 is for allowing air or other fluids to enter the infection protection capsule 1 from the outside. The shape of the sole cover part 5 is semicircular, but is not limited to this, and may be any shape that can be joined to the body cover part 2 and is the same shape as the overhead cover part 4.

The material of the sole cover part 5 may be any material that does not affect the X-rays or electromagnetic waves used in CT scans or MRI scans. The material of the sole cover part 5 may be a CFRP (carbon fiber reinforced plastic) plate, wood, Bakelite plate, MC nylon plate, Teflon plate, polystyrene plate, graphite plate, polypropylene plate, ABS resin plate, or polypentane acetal (POM) plate. Wood is preferable, and polycarbonate may be attached to the patient side. This makes it easier to disinfect the inside of the infection protection capsule.

The air intake filter 5a is for purifying the air from outside the infection protection capsule. The air intake filter 5a may be an air purification filter with little pressure loss. This allows purified air to be taken into the infection protection capsule 1.

When the above-mentioned bottom part 3, overhead cover part 4, and sole cover part 5 are made of wood, a thin (0.5 mm or more) polycarbonate may be adhered to the inside of the capsule. This makes it easier to disinfect the inside of the capsule by wiping, etc. Also, a photocatalytic coating may be applied to the inside of the infection protection capsule 1. This allows the inside of the capsule to be disinfected by UV irradiation more effectively than UV irradiation alone.

The exhaust mechanism 6 exhausts the air inside the infection protection capsule 1. The exhaust mechanism 6 may be formed near either the overhead cover part 4 or the sole cover part 5. Preferably, it is the overhead cover part 4. By forming the exhaust mechanism 6 near the overhead cover part 4, it is possible to make it difficult for infectious microorganisms contained in the patient's droplets to scatter to the soles of the patient's feet. The exhaust mechanism 6 may be formed either inside the infection protection capsule 1 or outside the infection protection capsule 1. The exhaust mechanism 6 may also have a nozzle that covers the opening of the overhead cover part 4 or the sole cover part 5, and a filter may be placed inside the nozzle. Furthermore, the exhaust mechanism 6 may be battery-powered, which allows the air inside the infection protection capsule 1 to be exhausted while moving. In the case of MRI imaging, if magnetic metal or a source of electromagnetic noise is located near the MRI device, it will adversely affect the image, so a non-magnetic exhaust duct such as resin or aluminum is connected to the infection protection capsule, and the exhaust device is installed in a position that does not affect the MRI image.

(Opening and closing of infection protection capsule 1)
Details of an example of how to use the infection protection capsule 1 will be described later, but a patient can be accommodated in the infection protection capsule 1 by opening the body cover part 2 as shown in Figure 2 (a), having the patient lie on the bottom part 3, and then closing the body cover part 2 as shown in Figure 2 (b).

Figure 3 is a partially enlarged view of Figure 1 (c) of the infection protection capsule according to one embodiment of the present invention. In the infection protection capsule 1, the body cover part 2 is engaged with the bottom part 3 and closed. The body cover part 2 is formed with a latch 2a made of a flexible material at its end, and a handle 2b is formed near the latch 2a on the outside of the capsule. The bottom part 3 is formed with an opening 3a, a plate part 3b, and a stopper part 3c. The stopper part 3c need only be something that does not easily come off when engaged with the body cover part 2, and may be, for example, an EPDM (Ethylene-Propylene-Diene Methylene linkage) rubber seal.

When the infection protection capsule 1 is closed, the body cover part 2 is inserted into the opening 3a of the bottom part 3 and engaged with the stopper part 3c. This allows the infection protection capsule 1 to be sealed.

On the other hand, when the infection protection capsule 1 is changed from a closed state to an open state, the handle 2b of the body cover part 2 is lifted up, disengaging the body cover part 2 from the stopper part 3c. Furthermore, if the patient feels discomfort, the body cover part 2 can be lifted from the inside, causing the body cover part 2 to detach from the bottom part 3, making it possible to exit the infection protection capsule 1.

The opening and closing structure of the infection protection capsule 1 may be a stopper portion of the body cover portion 2 and the bottom portion 3 on one side, and a hinge structure on the other side. In addition, it is not limited to the above-mentioned opening and closing structure, and conventional technology may be used, such as Velcro (registered trademark). This allows the airtightness inside the infection protection capsule 1 to be maintained.

(Negative pressure inside the infection protection capsule)
Next, the negative pressure in the infection protection capsule according to one embodiment of the present invention will be described with reference to Fig. 4. Fig. 4(a) to (c) are graphs showing the results when the suction speed U is changed. Fig. 4(a) to (c) show the differential pressure (Pa) on the vertical axis and the length of the infection protection capsule on the horizontal axis.

Figure 4 (d) is a schematic diagram showing the measurement conditions for the infection protection capsule. On the paper, the object represents the patient, the left side represents the sole cover, and the right side represents the overhead cover. Negative pressure is created inside the infection protection capsule 1 by suction (exhaust) from the overhead cover side. In Figures 4 (a) to (c), the suction speed is changed to 1.0 m/s, 2.0 m/s, and 4.0 m/s, respectively, and the pressure difference between the 1.05 m and 1.8 m positions is large, resulting in an overall negative pressure state.

In this way, negative pressure can be created inside the infection protection capsule by suctioning (exhausting) air from the overhead cover, and infectious microorganisms are not discharged outside the infection protection capsule.

(Disinfection of infection protection capsules)
Fig. 5 is a graph showing the disinfection results of UV irradiation of the infection protection capsule 1 according to one embodiment of the present invention. In Fig. 5, the vertical axis shows the absorbance of methylene blue, and the horizontal axis shows each treatment condition for polycarbonate. As a disinfection method, a photocatalyst is applied to the polycarbonate, and disinfection is performed by UV irradiation for 90 minutes (UV intensity 5 μW/cm ² ). The more the methylene blue pigment decomposition progresses, the stronger the disinfection effect becomes, and the lower the absorbance at a wavelength of 644 nm becomes.

FIG. 5 shows the results of the following cases: no UV irradiation (No UV), UV irradiation only (UV Only), application of a photocatalyst at ×1/125 and UV irradiation (×1/125), application of a photocatalyst at ×1/25 and UV irradiation (×1/25), application of a photocatalyst at ×1/5 and UV irradiation (×1/5), and application of a photocatalyst at ×1 and UV irradiation (×1). Here, ×1 is the application concentration of the photocatalyst (NanoPhos SurfaShield) of 74 μL/cm ² , and the others indicate the dilution ratio. As the disinfection results show, the disinfection effect was obtained when the application concentration of the photocatalyst was ×1/5 and ×1 for polycarbonate.

In this way, a certain level of disinfection effect can be achieved by applying a photocatalyst to polycarbonate and irradiating it with UV light.

Figure 6 is a graph showing the disinfection results of the infection protection capsule 1 according to one embodiment of the present invention. The graph shows the results of measuring the lysis plaques caused by E. coli infection with the φX174 phage virus when disinfected with UV alone, UV + photocatalyst, 0.05% sodium hypochlorite, and 75% disinfectant ethanol. This shows that the number of plaques is smaller when photocatalyst is used in combination with UV than when UV alone, i.e., there is less residual virus and the disinfection effect is higher. Wiping with sodium hypochlorite or disinfectant ethanol is even more effective. In other words, while disinfection by wiping is effective for the inside of the protective cover, it can also be disinfected non-contact with UV, etc. to reduce the risk of infection.

The φX174 phage virus has DNA as its nucleic acid and is about 30 nm in size, so it is thought to have higher disinfection resistance and easier penetration than the 100 nm coronavirus, which has RNA as its nucleic acid. The test using φX174 infection with E. coli is a test method specified in the Japanese Industrial Standard JIS. T 8061: 2015. "Protective clothing against contact with blood and body fluids - Determination of penetration resistance of protective clothing materials against blood-borne pathogens", and this experimental system was applied in this experiment.

Figure 7 is a schematic cross-sectional view of a virus sprayed into an infection protection capsule according to one embodiment of the present invention, and a graph showing the results of measuring lytic plaques. Polycarbonate sample plates were placed at five locations inside the infection protection capsule. The exhaust device 6 was operated, and a culture solution containing the φX174 phage virus was sprayed directly upward in an intake state on the inside near the overhead cover part 4 of the infection protection capsule. One of the plates was coated with a photocatalyst (titanium oxide). After that, the plate was disinfected with UV irradiation and a 0.05% sodium hypochlorite wipe, and the virus attached to the sample plate was collected and infected with E. coli. No residual virus was detected with either disinfection method, and sufficient disinfection effects were observed.

Figure 8 is a graph showing the measurement results of the number of plaques over time when a virus is sprayed on a material used for an infection protection capsule according to one embodiment of the present invention. Polycarbonate plates, aluminum plates, and copper plates are compared as materials used for infection protection capsules. A culture solution containing φX174 phage virus was sprayed on each plate and on a mask, and the number of plaques due to live viruses contained in the culture solution collected after 1 hour, 2 hours, 3 hours, 6 hours, and 16 hours was measured. The number of plaques indicating residual viruses decreased over time, and almost all of the viruses were killed in about 12 hours. In other words, the phage viruses were killed almost overnight on polycarbonate plates, aluminum plates, and masks at a temperature of 25°C and a humidity of 65%. However, only copper was not found to have any virus survival from the beginning. Copper is easily eluted as a cationic ion, so it is presumed to have an antibacterial effect. In other words, a thin copper film has a bactericidal effect on its surface, so by attaching it to the edge of a protective cover that is difficult to disinfect, it exerts a disinfecting effect. Therefore, by attaching copper foil tape with a thickness of 50 μm or less and a width of 10 mm or less, or copper vapor deposition tape with a thickness of 1 μm or less (preferably 0.1 μm or less and a width of 10 mm or less) to the edge of the protective cover, the tape itself can exert a disinfecting effect. Furthermore, this thickness does not affect the image quality during CT scans.

Figure 9 shows a modified infection protection capsule according to one embodiment of the present invention. As shown in Figure 1(b), the volume is approximately the same from the patient's feet to their shoulders, but the volume decreases from the patient's shoulders to their head, which can cause the air flow to become turbulent and create a stagnation area in this area. For this reason, in Figure 9, a pillow 1a is provided for the patient so that the volume does not decrease from the patient's shoulders to their head. This makes it difficult for a stagnation area to occur from the patient's shoulders to their head, and creates a stable unidirectional flow field inside the infection protection capsule.

In addition, while in FIG. 1 the shape of the body cover part 2 is a single sheet, in FIG. 9 the shape of the body cover part 20 is two sheets 21, 22 whose ends are joined together via sheet B. This makes it easier for a patient inside the infection protection capsule to escape from the capsule in an emergency by pushing the body cover part 20 from the inside.

The body cover section 20 also includes a line port 1b for passing a tube such as an IV drip, a glove port 1c for inserting a glove into the protective capsule, and a ventilation window 1d for communication between the measurer and the patient.

Line port 1b is for passing tubes through and is sealed with a rubber stopper when not in use. This allows the facility to accommodate patients who require intravenous drips or oxygen masks.

The glove port 1c is for passing a glove through, and when not in use, the line port is similarly blocked with a sealable rubber plug or the like. This allows the patient to be assisted without opening the body cover portion 20 when assistance is required inside the infection protection capsule.

The ventilation window 1d is an opening provided in the body cover part 20, and a filter is attached around the opening so as to cover the opening. This allows the person taking the measurement and the patient to talk to each other.

A CT scan method using an infection protection capsule according to one embodiment of the present invention will be described. First, a patient is accommodated in the infection protection capsule in a room where positive or suspected positive patients are waiting, separate from the room where the CT scanner is installed. At this time, a cushion or the like is inserted to adjust the patient's imaging center height so that it matches the isoline marker A of the overhead cover part 4 or the sole cover part 5 and the virtual line A' of the body cover part 2 according to the patient's body shape. For patients wearing oxygen masks or receiving intravenous drips, a line is taken out from the line port 1b that penetrates the body cover part 2 and connected to an oxygen cylinder or an intravenous drip bag. After covering and sealing the body cover part 2, suction (exhaust) is performed from the overhead cover part of the infection protection capsule to create negative pressure inside the infection protection capsule. After that, the infection protection capsule is moved on a stretcher or the like to the room where the CT scanner is installed. Then, the infection protection capsule is transferred to the CT scanner measurement table as it is, and the CT scan measurement is started. The operator can visually check the inside of the infection protection capsule and talk through the ventilation window 1d, so that he or she can adjust the position and check the patient's condition as appropriate. If the patient's condition suddenly changes, or if the oxygen mask or IV drip becomes displaced and emergency assistance is required inside the protective cover, the operator puts on airtight long gloves through the glove port 1c and keeps the gloves on until the patient leaves. After the CT scan measurement, the patient is moved back to the original patient waiting room, the infection protection capsule is opened, and the patient leaves. After that, the medical staff disinfects the inside of the infection protection capsule with disinfectant alcohol, sodium hypochlorite, hypochlorous acid water, etc., or by irradiating it with ultraviolet light. By preparing multiple such infection protection capsules and using them in rotation, the examination time for infected patients can be shortened.

In this way, infectious microorganisms can be kept inside the infection protection capsule, making it possible to inhibit the spread of infectious microorganisms.

Therefore, it is possible to perform measurements using diagnostic imaging methods such as CT or MRI while avoiding the spread of infectious diseases to medical staff and general patients, and furthermore, the inside of the infection protection capsule can be easily sterilized so that it can be reused after measurements have been taken.

REFERENCE SIGNS LIST 1 Infection protection capsule 2 Body cover section 2a Latch 2b Handle 3 Bottom section 3a Opening 3b Plate section 3c Stopper section 3A to 3D End section of bottom section 4 Overhead cover section 4a Exhaust filter 5 Sole cover section 5a Air supply filter 6 Exhaust mechanism 10 Medical image processing device

Claims (15)

An infection protection capsule for accommodating a patient and used for medical imaging, comprising:
The device comprises a body cover part for covering a patient, a bottom part on which the patient lies, an overhead cover part located above the patient's head, a foot cover part located at the patient's feet, and an exhaust mechanism in fluid communication with either the overhead cover part or the foot cover part via an opening and a filter;
The exhaust mechanism creates a negative pressure inside the infection protection capsule,
The body cover part is openably and closably engaged with the bottom part,
The infection protection capsule is characterized in that at least a portion of the inside of the infection protection capsule is coated with a photocatalyst . 2. The infection protection capsule according to claim 1, wherein the body cover portion has ends parallel to the longitudinal direction, and the ends of the body cover portion and the ends of the bottom portion are engaged with each other. 3. The infection protection capsule according to claim 1, wherein the body cover portion and the bottom portion are made of a material that is not affected by X-rays or electromagnetic waves emitted during the medical image capture . The infection protection capsule according to claim 3, characterized in that the material is made of a thermoplastic resin. An infection protection capsule as described in claim 3 or 4, characterized in that the material is polycarbonate or PET. The infection protection capsule according to any one of claims 1 to 5 , characterized in that the filter is a HEPA filter. The infection protection capsule according to any one of claims 1 to 6 , characterized in that the exhaust mechanism is battery-powered. The infection protection capsule according to any one of claims 1 to 7 , characterized in that the medical image capturing is performed by an X-ray CT scanner or an MRI scanner. The infection protection capsule according to any one of claims 1 to 8 , characterized in that the body cover portion of the infection protection capsule is expanded into a sheet shape . The infection protection capsule according to any one of claims 1 to 9 , characterized in that the infection protection capsule is irradiated with ultraviolet light inside the infection protection capsule. The infection protection capsule according to any one of claims 1 to 10 , characterized in that at least one of the overhead cover portion and the sole cover portion is provided with an isoline marker. The infection protection capsule according to any one of claims 1 to 11, characterized in that the body cover portion has a copper foil tape having a thickness of 50 μm or less or a copper vapor deposition tape having a copper thickness of 1 μm or less around at least one end portion, and the copper foil tape or copper vapor deposition tape does not affect the medical image capture. The infection protection capsule according to any one of claims 1 to 12 , characterized in that the body cover portion has a body cover opening, and a filter is formed so as to cover the body cover opening. The infection protection capsule according to any one of claims 1 to 13 , characterized in that the body cover portion further comprises a glove port for a work glove within the infection protection capsule. The infection protection capsule according to any one of claims 1 to 14 , characterized in that the body cover portion further comprises a port for passing a tube into the infection protection capsule.

Images